Increasing physical activity levels using e-bikes to enhance prostate cancer survival: a randomised pilot study

niversity of Bristol0 个研究点目标入组 30 人开始时间: 2022年4月8日最近更新: 2024年9月2日

适应症

试验速览

2023 Protocol article in https://doi.org/10.1186/s40814-023-01293-3 (added 25/04/2023) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/39151159/ The development of the CRANK intervention (added 19/08/2024)

•1. Men with high-risk localised prostate cancer (PSA >20 or clinical stage =cT2c or Gleason 8/9/10 (NICE Guidance definition)), OR men with locally advanced prostate cancer (in addition to the above, T3b and T4, N0 prostate cancer; and any T, N1 prostate cancer), OR men with metastatic prostate cancer (stage M1)
•2. Aged 18 years or over
•3. Cleared for engaging in physical activity by the treating consultant
•For the instructor/coordinator interviews the inclusion criterion is that individuals have coordinated the CRANK project or delivered e-bike training to participants in the CRANK trial.
•For healthcare professionals the inclusion criterion for participating in the interviews is that they have been involved in identifying and/or recruiting individuals for the CRANK-P trial.

•1. Engage in =150 minutes of moderate-to-vigorous physical activity per week
•2. Uncontrolled hypertension (systolic blood pressure (BP) >160 mmHg and/or diastolic BP >90 mmHg), for which the individual is not taking medication
•3. Comorbidities including myocardial infarction or stroke within the past 6 months or evidence of end-stage renal failure or liver disease, uncontrolled congestive heart failure or angina
•4. Use of a mobility aid preventing cycling
•5. No previous experience riding a bicycle
•6. Any other contra-indications to exercise
•7. Are unable to read and communicate in English

发起方

niversity of Bristol